Corrigendum to 'Gut Microbiota in Advanced NSCLC Receiving Chemoimmunotherapy: An Ancillary Biomarker Study From the Phase III Trial JCOG2007 (NIPPON)' [Journal of Thoracic Oncology Vol. 20 No. 7 (2025) 912-927]

Affiliations

¹ Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo, Tokyo, Japan. Electronic address: t-hakozaki@akane.waseda.jp.
² Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Higashi, Fukuoka, Japan.
³ Japan Clinical Oncology Group Operations Office, National Cancer Center Hospital, Chuo, Tokyo, Japan.
⁴ Department of Thoracic Oncology, National Cancer Center Hospital, Chuo, Tokyo, Japan.
⁵ Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Miyagi, Japan.
⁶ Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan.
⁷ Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
⁸ Department of Respiratory Medicine, Itami City Hospital, Itami, Hyogo, Japan.
⁹ Department of Respiratory Medicine, Akita Kousei Medical Center, Akita, Akita, Japan.
¹⁰ Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, Mibu, Tochigi, Japan.
¹¹ Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
¹² Department of Thoracic Oncology, NHO Kyushu Cancer Center, Minami, Fukuoka, Japan.
¹³ Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo, Tokyo, Japan.

Published Erratum

Taiki Hakozaki et al. J Thorac Oncol. 2025 Nov.

. 2025 Nov;20(11):1722.

doi: 10.1016/j.jtho.2025.09.004. Epub 2025 Oct 7.

¹ Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo, Tokyo, Japan. Electronic address: t-hakozaki@akane.waseda.jp.
² Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Higashi, Fukuoka, Japan.
³ Japan Clinical Oncology Group Operations Office, National Cancer Center Hospital, Chuo, Tokyo, Japan.
⁴ Department of Thoracic Oncology, National Cancer Center Hospital, Chuo, Tokyo, Japan.
⁵ Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Miyagi, Japan.
⁶ Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan.
⁷ Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
⁸ Department of Respiratory Medicine, Itami City Hospital, Itami, Hyogo, Japan.
⁹ Department of Respiratory Medicine, Akita Kousei Medical Center, Akita, Akita, Japan.
¹⁰ Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, Mibu, Tochigi, Japan.
¹¹ Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
¹² Department of Thoracic Oncology, NHO Kyushu Cancer Center, Minami, Fukuoka, Japan.
¹³ Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo, Tokyo, Japan.

No abstract available

Erratum for

Gut Microbiota in Advanced NSCLC Receiving Chemoimmunotherapy: An Ancillary Biomarker Study From the Phase III Trial JCOG2007 (NIPPON).
Hakozaki T, Tanaka K, Shiraishi Y, Sekino Y, Mitome N, Okuma Y, Aiba T, Utsumi T, Tanizaki J, Azuma K, Hara S, Morita R, Niho S, Yokoyama T, Toyozawa R, Horinouchi H, Okamoto I, Hosomi Y, Ohe Y. Hakozaki T, et al. J Thorac Oncol. 2025 Jul;20(7):912-927. doi: 10.1016/j.jtho.2025.02.026. Epub 2025 Mar 7. J Thorac Oncol. 2025. PMID: 40058642 Clinical Trial.